Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Estimating the Size of the Hidden Population of COVID-19

Author(s): Esmaeil Mehraeen, Fatemeh Khajeh Akhtaran, Mohammad Reza Faridrohani, Arian Afzalian, Hengameh Mojdeganlou, Zeinab Ghanbari, Yasamin Fathzadeh, Mohadeseh Gholizadeh, SeyedAhmad SeyedAlinaghi* and Daniel Hackett

Volume 24, Issue 2, 2024

Published on: 31 October, 2023

Article ID: e311023222945 Pages: 9

DOI: 10.2174/0118715265255039231018113634

Price: $65

Abstract

Introduction: An asymptomatic population has the same infection as symptomatic individuals, so these individuals can unknowingly spread the virus. It is not possible to predict the rate of epidemic growth by considering only the identified isolated or hospitalized population. In this study, we want to estimate the size of the COVID-19 population, based on information derived from patients visiting medical centers. So, individuals who do not receive a formal diagnosis in those medical centers can be considered as hidden.

Methodology: To estimate the Bayesian size of the hidden population of COVID-19 a respondentdriven sampling (RDS) method was used. Twenty-three people infected with COVID-19 seeds and who had positive PCR test results were selected as seeds. These participants were asked whether any of their friends and acquaintances who had COVID-19 did not visit a medical center or hid their illness. Access to other patients was gained through friendship and kinship, hence allowing the sampling process to proceed.

Results: Out of 23 selected seeds, only 15 seeds remained in the sample and the rest were excluded due to not participating in the further sampling process. After 5 waves, 50 people with COVID-19 who had hidden their disease and were not registered in the official statistics were included in the sample. It was estimated that 12,198 people were infected with COVID-19 in Khalkhal city in 2022. This estimate was much higher than recorded in the official COVID-19 statistics.

Conclusions: The study findings indicate that the estimated 'true' numbers of COVID-19 patients in one town in Iran were significantly higher compared to the official numbers. The RDS method can help capture the potential size of infections in further pandemics or outbreaks globally.

Graphical Abstract

[1]
SeyedAlinaghi S, Karimi A, MohsseniPour M, et al. The clinical outcomes of COVID-19 in HIV-positive patients: A systematic review of current evidence. Immun Inflamm Dis 2021; 9(4): 1160-85.
[http://dx.doi.org/10.1002/iid3.497] [PMID: 34324280]
[2]
Dadras O, SeyedAlinaghi S, Karimi A, et al. COVID-19 mortality and its predictors in the elderly: A systematic review. Health Sci Rep 2022; 5(3): e657.
[3]
SeyedAlinaghi S, Karimi A, Mojdeganlou H, et al. Impact of COVID-19 pandemic on routine vaccination coverage of children and adolescents: A systematic review. Health Sci Rep 2022; 5(2): e00516.
[PMID: 35224217]
[4]
Oliaei S, SeyedAlinaghi S, Mehrtak M, et al. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): A systematic review. Eur J Med Res 2021; 26(1): 96.
[5]
Nishiura H, Kobayashi T, Miyama T, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 2020; 94: 154-5.
[http://dx.doi.org/10.1016/j.ijid.2020.03.020] [PMID: 32179137]
[6]
Tuite AR, Ng V, Rees E, Fisman D. Estimation of COVID-19 outbreak size in Italy. Lancet Infect Dis 2020; 20(5): 537.
[7]
Böhning D, Rocchetti I, Maruotti A, Holling H. Estimating the undetected infections in the Covid-19 outbreak by harnessing capture-recapture methods. Int J Infect Dis 2020; 97: 197-201.
[http://dx.doi.org/10.1016/j.ijid.2020.06.009] [PMID: 32534143]
[8]
Ocagli H, Azzolina D, Lorenzoni G, et al. Using social networks to estimate the number of COVID-19 Cases: The incident (hidden COVID-19 cases network estimation) study protocol. Int J Environ Res Public Health 2021; 18(11): 5713.
[http://dx.doi.org/10.3390/ijerph18115713] [PMID: 34073448]
[9]
Comiskey CM, Snel A, Banka PS. First back-calculation and infection fatality multiplier estimate of the hidden prevalence of COVID-19 in Ireland. Eur J Public Health 2021; 31(4): 908-12.
[http://dx.doi.org/10.1093/eurpub/ckab126] [PMID: 34245277]
[10]
Vaid S, Cakan C, Bhandari M. Using machine learning to estimate unobserved COVID-19 infections in North America. J Bone Joint Surg Am 2020; 102(13): e70.
[http://dx.doi.org/10.2106/JBJS.20.00715] [PMID: 32618918]
[11]
Barrie MB, Lakoh S, Kelly JD, et al. SARS-CoV-2 antibody prevalence in Sierra Leone. medRxiv 2021.
[12]
Salganik MJ, Heckathorn DD. 5. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol 2004; 34(1): 193-240.
[http://dx.doi.org/10.1111/j.0081-1750.2004.00152.x]
[13]
Handcock MS, Gile KJ, Mar CM. Estimating hidden population size using respondent-driven sampling data. Electron J Stat 2014; 8(1): 1491-521.
[http://dx.doi.org/10.1214/14-EJS923] [PMID: 26180577]
[14]
Gile KJ. Improved inference for respondent-driven sampling data with application to HIV prevalence estimation. J Am Stat Assoc 2011; 106(493): 135-46.
[http://dx.doi.org/10.1198/jasa.2011.ap09475]
[15]
West M. Inference in successive sampling discovery models. J Econom 1996; 75(1): 217-38.
[http://dx.doi.org/10.1016/0304-4076(95)01777-1]
[16]
Abadie R, Habecker P, Carrasco KG, et al. Employing respondent driven sampling (RDS) to recruit people who inject drugs (PWID) and other hard-to-reach populations during COVID-19: Lessons learned. Front Psychiatry 2022; 13: 990055.
[http://dx.doi.org/10.3389/fpsyt.2022.990055] [PMID: 36262631]
[17]
Abadie R, Welch-Lazoritz M, Bilal K, Dombrowski K. Social determinants of HIV/HCV co-infection: A case study from people who inject drugs in rural Puerto Rico. Addict Behav Rep 2017; 5: 29-32.
[http://dx.doi.org/10.1016/j.abrep.2017.01.004] [PMID: 28983502]
[18]
Lee S, Ong AR, Elliott M. Exploring mechanisms of recruitment and recruitment cooperation in respondent driven sampling. J Off Stat 2020; 36(2): 339-60.
[http://dx.doi.org/10.2478/jos-2020-0018] [PMID: 33162642]
[19]
Wylie JL, Jolly AM. Understanding recruitment: outcomes associated with alternate methods for seed selection in respondent driven sampling. BMC Med Res Methodol 2013; 13(1): 93.
[http://dx.doi.org/10.1186/1471-2288-13-93] [PMID: 23865487]
[20]
Kazerooni PA, Motazedian N, Motamedifar M, et al. The prevalence of human immunodeficiency virus and sexually transmitted infections among female sex workers in Shiraz, South of Iran: By respondent-driven sampling. Int J STD AIDS 2014; 25(2): 155-61.
[http://dx.doi.org/10.1177/0956462413496227] [PMID: 23970644]
[21]
Wickersham JA, Gibson BA, Bazazi AR, et al. Prevalence of human immunodeficiency virus and sexually transmitted infections among cisgender and transgender women sex workers in greater Kuala Lumpur, Malaysia: Results from a respondent-driven sampling study. Sex Transm Dis 2017; 44(11): 663-70.
[http://dx.doi.org/10.1097/OLQ.0000000000000662] [PMID: 28708696]
[22]
Oliveira MP, Matos MAD, Silva ÁMC, et al. Prevalence, risk behaviors, and virological characteristics of hepatitis B virus infection in a group of men who have sex with men in Brazil: Results from a respondent-driven sampling survey. PLoS One 2016; 11(8): e0160916.
[http://dx.doi.org/10.1371/journal.pone.0160916] [PMID: 27508385]
[23]
Solomon SS, McFall AM, Lucas GM, et al. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis. PLoS Med 2017; 14(11): e1002460.
[http://dx.doi.org/10.1371/journal.pmed.1002460] [PMID: 29182638]
[24]
Khamsiriwatchara A, Wangroongsarb P, Thwing J, et al. Respondent-driven sampling on the Thailand-Cambodia border. I. Can malaria cases be contained in mobile migrant workers? Malar J 2011; 10(1): 120.
[http://dx.doi.org/10.1186/1475-2875-10-120] [PMID: 21554744]
[25]
Mukherjee M, Maity C, Chatterjee S. Media use pattern as an indicator of mental health in the COVID-19 pandemic: Dataset from India. Data Brief 2021; 34: 106722.
[http://dx.doi.org/10.1016/j.dib.2021.106722] [PMID: 33490336]
[26]
Johnson CA, Tran DN, Mwangi A, et al. Incorporating respondent-driven sampling into web-based discrete choice experiments: Preferences for COVID-19 mitigation measures. Health Serv Outcomes Res Methodol 2022; 22(3): 297-316.
[http://dx.doi.org/10.1007/s10742-021-00266-4] [PMID: 35035272]
[27]
Helms YB, Hamdiui N, Kretzschmar MEE, et al. Applications and recruitment performance of web-based respondent-driven sampling: Scoping review. J Med Internet Res 2021; 23(1): e17564.
[http://dx.doi.org/10.2196/17564] [PMID: 33448935]
[28]
Rocchetti I, Böhning D, Holling H, Maruotti A. Estimating the size of undetected cases of the COVID-19 outbreak in Europe: An upper bound estimator. Epidemiol Methods 2020; 9(s1): 20200024.
[http://dx.doi.org/10.1515/em-2020-0024]
[29]
Rippinger C, Bicher M, Urach C, et al. Evaluation of undetected cases during the COVID-19 epidemic in Austria. BMC Infect Dis 2021; 21(1): 70.
[http://dx.doi.org/10.1186/s12879-020-05737-6] [PMID: 33441091]
[30]
Mehraeen E, Pashaei Z, Akhtaran FK, et al. Estimating methods of the undetected infections in the COVID-19 outbreak: A systematic review. Infect Disord Drug Targets 2023; 23(4): e240123213106.
[http://dx.doi.org/10.2174/1871526523666230124162103] [PMID: 36698234]
[31]
Mehraeen E, Dadras O, Afsahi AM, et al. Vaccines for COVID-19: A systematic review of feasibility and effectiveness. Infect Disord Drug Targets 2022; 22(2): e230921196758.
[http://dx.doi.org/10.2174/1871526521666210923144837] [PMID: 34554905]
[32]
Mehraeen E, Najafi Z, Hayati B, et al. Current treatments and therapeutic options for COVID-19 patients: A systematic review. Infect Disord Drug Targets 2022; 22(1): e260721194968.
[http://dx.doi.org/10.2174/1871526521666210726150435] [PMID: 34313204]
[33]
Mehraeen E, Salehi MA, Behnezhad F, Moghaddam HR. SeyedAlinaghi S. Transmission modes of COVID-19: A systematic review. Infect Disord Drug Targets 2021; 21(6): e170721187995.
[http://dx.doi.org/10.2174/1871526520666201116095934] [PMID: 33200716]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy